Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2000
10/18/2000EP0827513A4 Methods of treatment and diagnostic visualisation, particularly in cancer
10/18/2000EP0648112B1 Precipitation of one or more active compounds in situ
10/18/2000CN1270529A Pharmaceutical compositions containing plasma protein
10/18/2000CN1270516A Pharmaceutical preparation comprising colodronate as active ingredient and silicified microcrystalline cellulose as excipient
10/18/2000CN1270514A Pharmaceutical composition for treating dymenorrhea and premature labor
10/18/2000CN1270029A Thebaic analgesic with controllable releasement of active content
10/18/2000CN1270028A Analgesic with controlled releasement of active content
10/18/2000CN1270027A Stable aqueous solution of phthalylglutamic acidimide derivative
10/18/2000CN1270026A Controlled releasing Qumaduo preparation having stably releasing mode and preparing method thereof
10/18/2000CN1270025A Method for preparing pills containing 90 wt.% activated pharmaceutical compositions
10/18/2000CN1057563C Bacterial stain of bacillus subtilis and application thereof
10/17/2000US6133426 Humanized anti-IL-8 monoclonal antibodies
10/17/2000US6133326 Compositions and methods for decreasing sebum production
10/17/2000US6133250 Oral 1α-hydroxyprevitamin D in methods for increasing blood level of activated vitamin D
10/17/2000US6133249 Phospholipid and propylene glycol based lubricant
10/17/2000US6133248 Polar drug of prodrug compositions with extended shelf-life storage and a method of making thereof
10/17/2000US6133235 Glucagon-like insulinotropic peptides compositions and methods
10/17/2000US6133026 Condensed plasmid-liposome complex for transfection
10/17/2000US6132769 Controlled release
10/17/2000US6132766 For drug delivery system; controlls release rate of encapsulated biologically active substance into biological fluids and in vivo
10/17/2000US6132762 Transcutaneous application of marijuana
10/17/2000US6132761 Percutaneous absorption preparation
10/17/2000US6132760 Contains a therapeutically effective amount of testosterone and a delivery enhancing adjuvant comprising a terpene.
10/17/2000US6132759 Medicaments containing gelatin cross-linked with oxidized polysaccharides
10/17/2000US6132758 A loratadine and an aminopolycarboxylic acid or a salt thereof.
10/17/2000US6132750 Particles of cross-linked proteins and polysaccharides with hydroxamic groups for chelating metals and their uses notably in cosmetics
10/17/2000US6132730 Combined tissue factor and factor VIIa methods and compositions for coagulation and tumor treatment
10/17/2000US6132729 Coagulation-deficient tissue factor for use in effecting specific coagulation and for use in tumor treatment
10/17/2000US6132723 Oligosaccharide hapten covalently coupled to carrier protein
10/17/2000US6132722 Recombinant antibody-enzyme fusion proteins
10/17/2000US6132713 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same
10/17/2000US6132712 Superoxide dismutase stabilized with fragments of casein and pharmaceutical compositions incorporating same
10/17/2000US6132699 Microencapsulated fluorinated gases for use as imaging agents
10/17/2000CA2193497C Controlled release aqueous emulsion
10/17/2000CA2178752C N-terminally chemically modified protein compositions and methods
10/17/2000CA2156726C Bisacodyl dosage form
10/17/2000CA2148071C Method of administering azithromycin
10/15/2000CA2305825A1 Novel bioactivating substance
10/12/2000WO2000060054A1 Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereof
10/12/2000WO2000059948A1 Method of forming agglomerates of polysaccharide with hydrophobic groups
10/12/2000WO2000059947A1 Enhanced gel strength methylcellulose
10/12/2000WO2000059863A1 Disodium salts, monohydrates, and ethanol solvates
10/12/2000WO2000059851A1 Derivatives of venlafaxine and methods of preparing and using the same
10/12/2000WO2000059629A1 Process for producing anion-layered double hydroxide intercalation compounds and products thus produced
10/12/2000WO2000059628A1 Mineral-salt based substantially or totally hydrosoluble composition, formulation containing said composition and production thereof
10/12/2000WO2000059627A1 Formulation arrays and use thereof
10/12/2000WO2000059548A1 Polyethyleneimine:dna formulations for aerosol delivery
10/12/2000WO2000059547A2 Method of detecting endometriosis
10/12/2000WO2000059546A2 Methods and compositions for drug delivery
10/12/2000WO2000059545A1 Modification of sexual behaviour in animals and pest control
10/12/2000WO2000059544A1 Stabilized compositions containing nootropic drugs
10/12/2000WO2000059543A1 Over-coated chewing gum formulations
10/12/2000WO2000059516A1 Compositions of polyacids and polyethers and methods for their use in reducing adhesions
10/12/2000WO2000059512A1 Formulation comprising testosteron undecanoate and castor oil
10/12/2000WO2000059508A1 Tolperison-containing, pharmaceutical preparation for oral administration
10/12/2000WO2000059488A2 Enhanced tissue and subcellular delivery of vitamin e compounds
10/12/2000WO2000059483A2 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000WO2000059482A1 Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants
10/12/2000WO2000059481A1 PHARMACEUTICAL DOSAGE FORM FOR PULSATILE DELIVERY OF d-threo-METHYLPHENIDATE AND A SECOND CNS STIMULANT
10/12/2000WO2000059480A1 Lyophilized solid dosage forms and methods of making
10/12/2000WO2000059479A1 Pharmaceutical dosage form for pulsatile delivery of methylphenidate
10/12/2000WO2000059478A1 Stabilised polyvinylpyrrolidone formulation
10/12/2000WO2000059477A1 Pregelatinized starch in a controlled release formulation
10/12/2000WO2000059476A1 Methods for fine powder formation
10/12/2000WO2000059475A1 Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
10/12/2000WO2000059474A1 Fusogenic lipids and vesicles
10/12/2000WO2000059473A1 Compositions and methods for treating lymphoma
10/12/2000WO2000059472A1 Propofol compositions containing preservative additives
10/12/2000WO2000059471A1 Propofol formulation with enhanced microbial characteristics
10/12/2000WO2000059447A2 Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding
10/12/2000WO2000059422A1 Apparatus and method to encapsulate, kill and remove malignancies, including selectively increasing absorption of x-rays and increasing free-radical damage to residual tumors targeted by ionizing and non-ionizing radiation therapy
10/12/2000WO2000041576A8 Improved microbial preparations
10/12/2000WO2000038747A3 Absorbent article composition and method of use for sequestering skin irritants
10/12/2000WO2000035422A3 Method of administering a compound to multi-drug resistant cells
10/12/2000WO2000033880A3 Conjugate used for enriching in neuronal cells
10/12/2000WO2000033874A3 Boron neutron capture therapy using pre-targeting methods
10/12/2000WO2000033869A3 Use of human prostrate cell lines in cancer treatment
10/12/2000WO2000033820A3 Nanoparticulate core-shell systems and use thereof in pharmaceutical and cosmetic preparations
10/12/2000WO2000033811A3 Improvements in or relating to powders
10/12/2000WO2000032227A3 Ordered molecular presentation of antigens, method of preparation and use
10/12/2000WO2000018440A9 Somatostatin receptor radioligand with increased uptake
10/12/2000WO1999065538A9 Medical device having anti-infective and contraceptive properties
10/12/2000DE19915862A1 Verwendung von molekulargewichtserweitertem Hirudin als Antikoagulans bei der extrakorporalen Nierenersatztherapie Use of molekulargewichtserweitertem hirudin as an anticoagulant in extracorporeal renal replacement therapy
10/12/2000DE19915420A1 Stabilisierte Polyvinylpyrrolidon-Zubereitungen Stabilized polyvinyl preparations
10/12/2000CA2487952A1 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
10/12/2000CA2368367A1 Pharmaceutical dosage form for pulsatile delivery of methylphenidate
10/12/2000CA2368185A1 Polyethyleneimine:dna formulations for aerosol delivery
10/12/2000CA2368083A1 Derivatives of venlafaxine and methods of preparing and using the same
10/12/2000CA2367100A1 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000CA2366884A1 Enhanced tissue and subcellular delivery of vitamin e compounds
10/12/2000CA2366880A1 Compositions of polyacids and polyethers and methods for their use in reducing adhesions
10/12/2000CA2366799A1 Propofol compositions containing preservative additives
10/12/2000CA2366791A1 Pharmaceutical dosage form for pulsatile delivery of d-threo-methylphenidate and a second cns stimulant
10/12/2000CA2366787A1 Compositions and methods for treating lymphoma
10/12/2000CA2366774A1 Method of detecting endometriosis
10/12/2000CA2365862A1 Mineral-salt based substantially or totally hydrosoluble composition, formulation containing said composition and production thereof
10/12/2000CA2365851A1 Formulation arrays and use thereof
10/12/2000CA2361885A1 Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding
10/12/2000CA2303702A1 Growth hormone and growth hormone releasing hormone compositions
10/11/2000EP1043345A1 Composition, particularly for cosmetics and pharmaceuticals, containing star shaped polymers, the polymers themselves and their use
1 ... 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 ... 1712